FLRA:XETRA:XETRA-Franklin Metaverse UCITS ETF USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 31.835

Change

-2.54 (-7.39)%

Market Cap

N/A

Volume

418.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.57 (-3.76%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.33 (-4.84%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.92 (-4.33%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.47 (-3.88%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.21 (-4.39%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-1.10 (-5.26%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.60 (-5.20%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.67 (+1.25%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.39 (-4.20%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.27 (-0.22%)

USD 12.26B

ETFs Containing FLRA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.95% 6% D- 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.95% 6% D- 8% B-
Trailing 12 Months  
Capital Gain -5.97% 18% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.97% 20% F 25% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.36% 91% A- 89% A-
Dividend Return 20.36% 91% A- 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.56% 18% F 30% F
Risk Adjusted Return 99.01% 83% B 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.